Hologic, Inc. HOLX reported adjusted earnings per share (EPS) of $1.03 in second-quarter fiscal 2024, down 2.8% year over year. However, the bottom line surpassed the Zacks Consensus Estimate by 6.2%.

VESICA HEALTH, INC., a leading multi-omics liquid biopsy company dedicated to improving the management of hematuria patients and the early detection of bladder cancer, today announced the launch of ...

As more provinces move towards Human papillomavirus (HPV) tests for cervical screening, most recently Ontario, questions ...

One participant said, "Honestly, I do look more at the HPV results than the cytology. I put more faith in knowing what their ...

Clinical psychologist Glenda Graham suffered delays in treatment for her endometrial cancer before her death in October 2020. Health NZ is now investigatin ...

Each of these are newer products to our portfolio, underscoring the power of our extended reach, layering on top of the strong U.S. molecular performance, international cytology was also accretive to ...

Experts reveal all about what is pap smear test, why it is done, its types, when are you supposed to do it, how frequently ...

While the top- and bottom-line numbers for Hologic (HOLX) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare ...

During the visit the inspector found that there were concerns over staffing levels at the practice, which is run by ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Fortune.com recently reported that artificial intelligence (AI) is helping the ...

Mauna Kea Technologies, the Paris-headquartered company whose “Cellvizio” laser endomicroscopy diagnostic platform is largely ...

Often the FNA cytology information can be augmented by submitting the material for flow cytometry or immunoperoxidase staining [Section-3 H8]. Any thyroid tissue in a lateral neck node is thyroid ...